Found: 5
Select item for more details and to access through your institution.
From Preclinics to Proof-of-Concept Clinical Trials.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2015, v. 77, n. 3, p. 344
- By:
- Publication type:
- Article
From Preclinics to Proof-of-Concept Clinical Trials A Development Pathway in Biotechnology.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2014, v. 76, n. 8, p. 344
- By:
- Publication type:
- Article
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S376, doi. 10.1016/S2152-2650(21)01860-7
- By:
- Publication type:
- Article
Poster: ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01533-0
- By:
- Publication type:
- Article
REDUCED NEAR-UV SENSITIVITY IN Phycomyces MUTANTS AFFECTED IN THE BIOSYNTHESIS OF 6,7-DIMETHYL-8-RIBITYLLUMAZINE.
- Published in:
- Photochemistry & Photobiology, 1995, v. 62, n. 3, p. 588, doi. 10.1111/j.1751-1097.1995.tb02389.x
- By:
- Publication type:
- Article